期刊文献+

黑龙江省乙型病毒性肝炎流行病学特征分析 被引量:2

Epidemiological characteristics of hepatitis B in Heilongjiang Province
原文传递
导出
摘要 目的分析1990—2019年黑龙江省乙型病毒性肝炎(以下简称乙肝)的流行病学特征。方法收集乙肝传染病监测资料,采用描述流行病学方法对1990—2019年黑龙江省乙肝流行特征进行分析。结果黑龙江省乙肝发病率从1990年起呈上升趋势,2005年至今呈下降趋势。分类报告的乙肝病例自2014年开始以慢性乙肝为主。结论多年来,新生儿和儿童乙肝疫苗免疫策略的实施已取得显著成效,今后仍要继续加强乙肝母婴阻断工作和乙肝诊断、报告管理工作。 Objective To analyze epidemiological characteristics of hepatitis B in Heilongjiang Province from 1990 to 2019.Methods Collecting the monitoring data of hepatitis B infection,and using descriptive epidemiological method to analyze the epidemiological characteristics of hepatitis B in Heilongjiang Province from 1990 to 2019.Results The incidence of hepatitis B in Heilongjiang Province has increased since 1990,and then has declined since 2005.Since2014,chronic hepatitis B has been the main category of reported hepatitis B cases.Conclusion Hepatitis B vaccine immunization strategy has made remarkable achievement in hepatitis B control for newborn and children.It is suggested to continue to strengthen interrupting mother-to-child transmission of hepatitis B virus,and the accuracy of diagnosis and report management of hepatitis B.
作者 张世婷 王锐 王晓宇 郎晓宇 宋长江 孙兆丹 赵亚双 ZHANG Shi-ting;WANG Rui;WANG Xiao-yu;LANG Xiao-yu;SONG Chang-jiang;SUN Zhao-dan;ZHAO Ya-shuang(School of Public Health,Harbin Medical University,Harbin,Heilongjiang 150081,China;不详)
出处 《中国公共卫生管理》 2022年第4期518-521,共4页 Chinese Journal of Public Health Management
关键词 乙型病毒性肝炎 流行病学特征 黑龙江 Hepatitis B epidemiological characteristic Heilongjiang
  • 相关文献

参考文献5

二级参考文献95

  • 1卢永,崔富强,王晓军,龚晓红,董红军,胡苑笙,陈园生,梁晓峰.中国八省市各级医疗机构确诊急性乙型肝炎实验室检测能力调查[J].中华流行病学杂志,2006,27(9):802-802. 被引量:22
  • 2龚江辉.城市入户调查的困境与出路[J].中国统计,2007,22(1):52-53. 被引量:11
  • 3崔富强,李庭栋,郭强.预防接种率调查评估比较[J].中国计划免疫,2007,13(2):170-174. 被引量:16
  • 4崔富强,卢永,王富珍,陈园生,郑徽,张勇,龚晓红,韩丽丽,董红军,陈超,凌罗亚,张丽,刁琳琪,邵晓萍,方刚,高丽,梁晓峰.中国2006年乙型肝炎报告病例构成分析[J].中华流行病学杂志,2007,28(9):872-874. 被引量:54
  • 5王富珍,崔富强,卢永,陈园生,郑徽,梁晓峰.中国8个省18个县(区)乙型病毒性肝炎监测病例分析[J].中国计划免疫,2007,13(4):309-312. 被引量:56
  • 6Liang XF, Bi SL, Yang WZ, et al. Epidemiological serosurvey of Hepatitis B in China-Declining HBV prevalence due to Hepatitis B vaccination[J]. Vaccine, 2009, 27(47): 6550-6557. DOI: 10.1016/j.vaccine. 2009.08.048.
  • 7Liu J, Zhang S, Wang Q, et al. Seroepidemiology of hepatitis B virus infection in 2 million men aged 21-49 years in rural China: a population-based, cross-sectional study[J]. Lancet Infect Dis, 2016,16(1):80-86. DOI: 10.1016/S1473-3099(15) 0021 8-2.
  • 8Yang S, Yu C, Chen P, et al. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China[J]. Sci Rep, 2015,5: 18334. DOI: 10.1038/srep18334.
  • 9Kao JH. Hepatitis B vaccination and prevention of hepatocellular carcinoma[J]. Best Pract Res Clin Gastroenterol, 2015,29 (6):907-917. DOI: 10.1016/j.bpg. 2015.09.011.
  • 10World Health Organization. Prevention and control of viral hepatitis infection [EB/OL]. [2016-03-24]. http://www.who.int/ hiv/Dub/heDatitis/Framework/en/.

共引文献187

同被引文献30

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部